Options Traders Expect Huge Moves in Karyopharm (KPTI) Stock

Options Traders Expect Huge Moves in Karyopharm (KPTI) Stock

Posted On January 20, 2020 4:41 pm

Investors in Karyopharm Therapeutics Inc. KPTI need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 21, 2020 $12.50 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Karyopharm shares, but what is the fundamental picture for the company? Currently, Karyopharm is a Zacks Rank #3 (Hold) in the Medical – Drugs industry that ranks in the Top 44% of our Zacks Industry Rank. Over the last 30 days, one analyst has increased the earnings estimates for the current quarter, while none have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from a loss of 67 cents to a loss of 66 cents in that period.

Given the way analysts feel about Karyopharm right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?

Check out the… Continue reading at Nasdaq.com

Tagged with:

About author

Related Articles